1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1281
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8107
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCSD-88612, NCI-V89-0023
|
|
5.
|
Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: NCI
Protocol IDs: CCG-321P4
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CAN-NCIC-HD6, E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 75
Sponsor:
Protocol IDs: WHO-MEL-TRIAL6, EU-95043
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: GER-NB90, EU-96004, NCT00002802
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 10 to 70
Sponsor: NCI
Protocol IDs: MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, NCT00002882
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-E3695, CLB-509802, SWOG-E3695, NCT00003027, E3695
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: ECOG-2496, CAN-NCIC-HD7, CALGB-59905, SWOG-E2496, E2496, NCT00003389, HD7
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-UKLG-LY09, EU-98020, NCT00003421
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: VCL-1005-301, NCT00003647
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-96001, EU-98028
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: SWOG-S9901, CLB-59802, E-S9901, NCT00005090, S9901
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0008, CALGB-500002, S0008, ECOG-S0008, COG-S0008, NCT00006237
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GM301, UCLA-0207109, NCT00016263
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-356
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-357
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-361
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-75HD301, SEG-366, SEG-75HD0103
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: BNLI-STANFORDV, EU-20206, NCT00041210
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-76LUN0103, SEG-365
|
